共 50 条
- [3] RESPONDER ANALYSES BASED ON MINIMUM CLINICALLY IMPORTANT DIFFERENCES DERIVED FROM RECEIVER OPERATING CHARACTERISTIC CURVES IN PREMENOPAUSAL WOMEN USING BREMELANOTIDE FOR FEMALE SEXUAL DYSFUNCTIONS JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S39 - S40
- [5] Re: Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial JOURNAL OF UROLOGY, 2016, 196 (05): : 1516 - 1517
- [6] Distress Reduction in Female Sexual Dysfunctions A Dose-Ranging Study of Subcutaneous Bremelanotide OBSTETRICS AND GYNECOLOGY, 2014, 123 : 29S - 30S
- [7] EPISODIC EFFICACY WITH SUBCUTANEOUS BREMELANOTIDE SELF-ADMINISTERED AT HOME BY PREMENOPAUSAL WOMEN WITH FEMALE SEXUAL DYSFUNCTION AS MEASURED BY THE FEMALE SEXUAL ENCOUNTER PROFILE-REVISED JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 220 - 220
- [9] Bremelanotide for Female Sexual Dysfunctions Responder Analyses From a Phase 2B Dose-Ranging Study OBSTETRICS AND GYNECOLOGY, 2014, 123 : 26S - 27S
- [10] Phase 2b bremelanotide study in premenopausal and postmenopausal women with female sexual arousal disorder OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 85S - 85S